Race Oncology Ltd. Statistics
Want to see AU:RAC full AI Analyst Report?
Race Oncology Ltd. (RAC) Stock Statistics & Valuation Metrics
Total Valuation
Race Oncology Ltd. has a market cap or net worth of AUD 307.83M. The enterprise value is AUD 367.74M.
- Market Cap
- AUD 307.83M
- Enterprise Value
- AUD 367.74M
Share Statistics
Race Oncology Ltd. has 196,068,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 196,068,940
- Owned by Insiders
- 10.36%
- Owned by Institutions
- ―
Financial Efficiency
Race Oncology Ltd.’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -27.25%.
- Return on Equity (ROE)
- -0.30
- Return on Assets (ROA)
- -0.29
- Return on Invested Capital (ROIC)
- -27.25%
- Return on Capital Employed (ROCE)
- -0.34
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.22M
- Employee Count
- 5
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Race Oncology Ltd. is -25.53. Race Oncology Ltd.’s PEG ratio is 0.27.
- PE Ratio
- -25.53
- PS Ratio
- 0.00
- PB Ratio
- 7.85
- Price to FCF
- -37.55
- Price to Operating Cash Flow
- -34.70
- PEG Ratio
- 0.27
Income Statement
In the last 12 months, Race Oncology Ltd. had revenue of 0 and earned -11.09M in profits. Earnings per share was -0.06.
- Revenue
- 0
- Gross Profit
- -281.31K
- Operating Income
- -12.43M
- Pretax Income
- -13.87M
- Net Income
- -11.09M
- EBITDA
- -12.15M
- Earnings Per Share (EPS)
- -0.06
Cash Flow
In the last 12 months, operating cash flow was -8.25M and capital expenditures -3,672, giving a free cash flow of -8.25M billion.
- Operating Cash Flow
- -8.25M
- Free Cash Flow
- -8.25M
- Free Cash Flow per Share
- -0.05
Dividends & Yields
Race Oncology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.48%
- Earnings Yield
- -3.60%
Stock Price Statistics
- Beta
- 0.04
- 52-Week Price Change
- -48.01%
- 50-Day Moving Average
- 1.82
- 200-Day Moving Average
- 2.25
- Relative Strength Index (RSI)
- 56.46
- Average Volume (3m)
- 85.21K
Important Dates
Race Oncology Ltd. upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 25, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Race Oncology Ltd. as a current ratio of 21.43, with Debt / Equity ratio of 0.00%
- Current Ratio
- 21.43
- Quick Ratio
- 21.43
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.82
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Race Oncology Ltd. has paid -2.78M in taxes.
- Income Tax
- -2.78M
- Effective Tax Rate
- 0.20
Enterprise Valuation
Race Oncology Ltd. EV to EBITDA ratio is -24.61, with an EV/FCF ratio of -36.25.
- EV to Sales
- 0.00
- EV to EBITDA
- -24.61
- EV to Free Cash Flow
- -36.25
- EV to Operating Cash Flow
- -36.26
Balance Sheet
Race Oncology Ltd. has AUD 34.29M in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 34.29M billion.
- Cash & Marketable Securities
- AUD 34.29M
- Total Debt
- AUD 0.00
- Net Cash
- AUD 34.29M
- Net Cash Per Share
- AUD 0.17
- Tangible Book Value Per Share
- AUD 0.19
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Race Oncology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -125.09%
Scores
- Smart Score
- 1
- AI Score
- 46
